Health Requirements and Recommendations for Travelers to

Saudi Arabia for Hajj – 1444h (2023)

The Ministry of Health in the Kingdom of Saudi Arabia issues this document to address health requirements and
recommendations for visitors traveling to Saudi Arabia for the purposes of Hajj, or seasonal works in Hajj areas
during 1444H (2023).

1 Required vaccinations:
Vaccine Target group Target countries Approved vaccine
SARS-COV-2 All travelers All countries https://www.moh.gov.sa/en/HealthAwareness/Pilgrims_Health/Approved-
Vaccines/Pages/Outside-the-Kingdom.aspx
(COVID-19) for Hajj
Meningococcal All All countries  Quadrivalent (ACYW) polysaccharide vaccine
meningitis individuals, within the last 3 years.
aged 1 year  Quadrivalent (ACYW) conjugate vaccine within the
and over, last 5 years.
arriving for  Health authorities at the pilgrims' country of origin
Hajj or for should ensure their vaccination within the
work in Hajj required validity period and make sure that the
zones1 type of vaccine is clearly shown in the vaccination
certificate. If the vaccine type is not indicated on
the certificate, it will be considered valid for 3
years only.
Poliomyelitis All travelers states reporting at least one dose of bivalent oral polio vaccine (bOPV)
cases of WPV1 or or inactivated polio vaccine (IPV)
cVDPV1
(Appendix 1-Table
1)
Poliomyelitis All travelers states reporting at least one dose of IPV3, if (IPV) is not available, it is
cVDPV2 positive acceptable to be vaccinated with at least one dose of
Human Sources the oral polio vaccine (OPV) 4.
samples or Acute
Flaccid Paralysis
(AFP) cases
(Appendix 1-Table
2)

_________ _______ _______ ______ _______ _______ ______ _______ _______ ______ _______ ______ _______ _______ ______ _______ _______ ______ _______ _______ ______ _______ ______ _______ _______ ______ _______ _______ ______

1 Makkah (the holy city), Madinah, Jeddah and Taif

2Current evidence suggests that conjugate vaccines are safe and effective for those above 55 years of age.
3 it is recommended to get (bOPV) or (IPV) dose within the previous 12 months and administered not less than 4 weeks prior to arrival.
4 it is recommended to get (OPV) dose within the previous 6 months and administered not less than 4 weeks prior to arrival.

Page 1 of 9
 Yellow Fever All travelers countries or areas Yellow fever vaccine. The Yellow Fever vaccination
above nine at risk of yellow certificate is valid for life starting 10 days after
months of fever vaccination.
age transmission
(Appendix 2)

2 Recommended vaccinations
Vaccine Target group Target countries Approved vaccine
Poliomyelitis All travelers states reporting positive at least one dose of (IPV)
Environmental Sources 5 , if (IPV) is not available,

samples of cVDPV2 it is recommended to be

(Appendix 1-Table 3) vaccinated with at least
one dose of the oral
polio vaccine (OPV) 6
Seasonal Influenza Travelers arriving for Hajj All countries Seasonal influenza
or for seasonal work in vaccine
Hajj areas particularly
pregnant women,
children under 5 years,
the elderly, individuals
with chronic medical
conditions (such as
chronic cardiac,
pulmonary, renal,
metabolic,
neurodevelopmental,
liver, or hematologic
diseases) and individuals
with immunosuppressive
conditions (such as
HIV/AIDS, receiving
chemotherapy or
steroids, or malignancy).

5 it is recommended to get (bOPV) or (IPV) dose within the previous 12 months and administered not less than 4 weeks prior to arrival.
6 it is recommended to get (OPV) dose within the previous 6 months and administered not less than 4 weeks prior to arrival.
Page 2 of 9
3 Preventive measures by health authority at points of entry
Disease Target countries Approved vaccine
SARS-COV-2 All countries. Comply with local preventive regulations and
(COVID-19) procedures required by the Public Health Authority,
available online on the fallowing link
(https://covid19.cdc.gov.sa/ ). These regulations are
continuously updated.
Meningococcal countries with frequent Administer prophylactic antibiotics at the points of
meningitis epidemics of meningococcal entry if deemed necessary.
meningitis, countries at risk
for meningitis epidemics, and
countries with outbreaks of
non-vaccine groups of N.
meningitides (Appendix 3)
Poliomyelitis states reporting cases of Administer one dose of bivalent oral polio vaccine
WPV1 or cVDPV1 (Appendix (bOPV) at points on entry to Saudi Arabia.
1-Table 1) regardless of age
and vaccination status.
Yellow fever Aircrafts, ships and other valid certificate indicating that disinsection was
means of transportation applied in accordance with methods
arriving from countries recommended by WHO. They may be subjected
affected by yellow fever to inspection as a condition of granting free
(Appendix 2)
pratique.
Zika Virus Disease Aircrafts, ships, and other valid certificate indicating that disinsection was
and Dengue Fever means of transportation applied in accordance with methods
arriving from countries recommended by WHO. They may be subjected
affected with the Zika virus to inspection as a condition of granting free
and/or dengue fever
pratique.
(Appendix 4)

5 it is recommended to get (bOPV) or (IPV) dose within the previous 12 months and administered not less than 4 weeks prior to arrival.
6 it is recommended to get (OPV) dose within the previous 6 months and administered not less than 4 weeks prior to arrival.
Page 3 of 9
4 General Health Recommendations.
4.1 Physical Ability, Chronic Diseases and Health Education
Ministry of Health recommends authorities at pilgrims’ countries of origin to consider the
physical ability and health conditions of individuals applying for Hajj. It also encourages to
consider the high risk of infectious diseases in the elderly and those with severe chronic diseases
such as advanced cancers, heart and respiratory diseases, advanced liver or kidney diseases, and
senility.
Pilgrims or those arriving for seasonal work or any other purpose in the Hajj areas with chronic
diseases, are requested to prove their health condition and the medicines they take, and bring a
sufficient amount of these medicines in their original packaging.
Pilgrims are recommended to update their vaccination status against vaccine-preventable
diseases. These include vaccination against Diphtheria, Tetanus, Pertussis, Polio, Measles,
Varicella and Mumps.
4.2 Acute Respiratory Infections:
All arriving travelers for Hajj or for seasonal work in Hajj zones are recommended to comply with
following:
 Wash hands with soap and water or a disinfectant, especially after coughing and
sneezing, after using toilets, before handling and consuming food, and after touching
animals.
 Use disposable tissues when coughing or sneezing and dispose of used tissues in a
wastebasket.
 Wear regular face masks when in crowded places.
 Avoid contact with those who appear ill and avoid sharing their personal belongings.
 Avoid visits and contact with camels in farms, markets, or barns, and avoid drinking
unpasteurized milk or eating raw meat or animal products that have not been
thoroughly cooked.
4.3 Food and Water-Borne Diseases
Authorities in Saudi Arabia do not permit entry of food with arriving travelers for Hajj except in
properly canned or sealed containers.
Pilgrims are recommended to observe the following:
 Wash hands before and after eating and after going to the toilet.
 Thoroughly clean and wash fresh vegetables and fruit.
 Cook food thoroughly and store at safe temperatures.
 Keep raw and cooked food separated.
4.4 Heat-Related Conditions

Page 4 of 9
 Pilgrims, especially older individuals, are recommended to avoid direct sun exposure while
performing rituals and to drink sufficient amount of fluids. Countries are requested to provide
education on health-related illness to their pilgrims prior to travel. Medications that can
exacerbate dehydration (e.g., diuretics) or interfere with heat exchange may need adjustment by
treating physicians.
4.5 Zika Virus Disease and Dengue Fever:
Pilgrims are recommended to take necessary measures to avoid mosquito bites during the day
and evening, which include wearing protective clothing (preferably light-colored) that covers as
much of the body as possible; using physical barriers such as window screens and closed doors;
and applying insect repellent (as per the label instructions on the product) to skin or clothing that
contains DEET, IR3535 or Icaridin.
5 Responding to International Health Events
In the case of a public health emergency of international concern, or in the case of any event subject to notification
under the International Health Regulations (2005), the Ministry of Health will undertake all additional necessary
measures in consultation with the WHO.

6 Hajj Medical Missions:

The Ministry of Health in the Kingdom of Saudi Arabia requires the medical missions accompanying the pilgrims
to comply with the following technical requirements:
 To have at least 1 physician per 1,000 pilgrims accompanying the mission.
 At least 20% of the accompanying physicians should be public health physicians.
 To have a valid medical waste contract with a certified local company that covers the entire Hajj season.
 Clinics should include at least one infectious diseases isolation room that meets Saudi Arabia Ministry of
Health standards.
 Commit to reporting notifiable infectious diseases to the Saudi Arabian Health System using approved
reporting methods.

Page 5 of 9
Appendix 1:
Table 1: States reporting cases of WPV1 or cVDPV1
WP1 cVDPV1
Afghanistan Madagascar
Mozambique Mozambique
Pakistan Malawi
DR Congo
Yemen
Congo

Table 2: States reporting cVDPV2 positive Human Sources samples or Acute Flaccid Paralysis (AFP) cases.

cVDPV2
Nigeria Ethiopia Algeria
Benin Chad Mali
Cameroon DR Congo Yemen
Central African Rep Ghana Somalia
Sudan Mozambique Niger
Indonesia United states of America Togo

Table 3: States reporting positive Environmental Sources samples of cVDPV2

cVDPV2
Canada Botswana United Kingdome
Egypt Côte d'Ivoire Zambia
Djibouti Palestine

Reference:
Statement of the Thirty-fourth Polio IHR Emergency Committee, held on 2 February 2023 – WHO

Appendix 2:
Page 6 of 9
Countries/areas at risk of Yellow Fever transmission, as per the WHO International Travel and Health
guidelines, are:

Americas Africa
Guyana Argentina Ghana Angola
Panama Venezuela Guinea Benin
Paraguay Bolivia Guinea-Bissau Burkina Faso
Peru Brazil Kenya Burundi
Surinam Colombia Liberia Cameroon
Ecuador Trinidad and Tobago Mali Central African Republic
French Guiana Mauritania Chad
Niger Congo
Nigeria Côte d’Ivoire
Senegal DR Congo
Sierra Leone Equatorial Guinea
Sudan Ethiopia
Gambia Gabon
Togo South Sudan
Uganda

Page 7 of 9
Appendix 3:
Countries/areas with frequent epidemics of meningococcal meningitis and countries at risk for
meningitis epidemics (WHO International Travel and Health, 2015):
Africa
Nigeria Ethiopia Benin
South Sudan Gambia Burkina Faso
Rwanda Ghana Burundi
Senegal Guinea Cameroon
Sudan Guinea-Bissau Central African Republic
Tanzania Kenya Chad
Togo Mali Côte d’Ivoire
Uganda Mauritania DR Congo
Niger Eritrea

Page 8 of 9
Appendix 4:
Countries with current or previous Zika virus transmission:
Asia Americas
Vietnam Fiji Bangladesh Dominica Anguilla
Papua New Guinea French Polynesia India Dominican Republic Antigua and Barbuda
Philippines Laos Indonesia Ecuador Argentina
Samoa Marshall Islands Maldives El Salvador Europa
Singapore Malaysia Myanmar French Guiana AL Bahama
Solomon Islands Micronesia Thailand Grenada Barbados
Tonga New Caledonia Cambodia Guadeloupe Belize
Vanuatu Palau Cook Islands Guatemala Bolivia
Africa Guyana Bonaire
Ethiopia Angola Haiti Sint Eustatius and
Saba
Gabon Burkina Faso Honduras Brazil
Guinea Bissau Burundi Isla de Pasqua - British Virgin Islands
Chelsea
Nigeria Cabo Verde Jamaica Caiman Islands
Senegal Cameroon Martinique Colombia
Uganda Central African Mexico Costa Rica
Republic
Côte d'Ivoire Montserrat Cuba
Nicaragua Curaçao
Saint Vincent and the Panama
Grindins
Saint Martin Paraguay
Suriname Peru
Trinidad and Tobago Puerto Rico
Turks and Caicos Saint Barthelemy
US Virgin Islands Saint Kitts and Nevis
Venezuela Saint Lucia
Saint Martin

Page 9 of 9